via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading
agency and financial media network dedicated to the North American
cannabis industry, announces publication of an article
discussing Aleafia Health Inc. (TSX-V: ALEF) (OTCQX:
ALEAF) (FRA: ARAH). The vertically-integrated licensed producer
with a clinic network and over 50,000 patients, was named as the
2019 TSX Venture 50 top performing company of the year. The
TMX Group’s annual performance awards are based on three equally
weight criteria, including market capitalization growth, share
price appreciation and trading volume.
The TSX Venture exchange has become a popular place for cannabis
companies to list their shares, particularly after Canada legalized
recreational cannabis last year, but 2019 was the first year that a
cannabis company topped its annual performance rankings.
The award demonstrates the company’s increasing popularity in
the space. Over the past 52 weeks, the company’s stock price rose
from a low of $0.47 to a high of $4.70 before settling at its
current levels of around $2.37, making it a popular stock for
active traders interested in the cannabis industry. As such, daily
trading volume averaged roughly 1.42 million shares over the past
three months, providing significant liquidity for investors.
Research Proves a Strong Catalyst
Aleafia Health’s stock reached all-time highs back in
late-September when it partnered with Cronos Group Inc.
to study the effects of medical cannabis on insomnia and daytime
sleepiness. Under the terms of the deal, Cronos Group would provide
funding for the study, which would be conducted by doctors at
Aleafia’s health clinics. The company also formally launched
Aleafia Labs to focus on these research projects.
The company’s stock also moved sharply higher when it
announced positive results from its benzodiazepine study.
After conducting a study with 146 patients, the company reported
that 45.2 percent of patients stopped consuming benzodiazepines—as
a sedative or anti-anxiety medication—following a medical cannabis
prescription. The patients further reported decreased daily
distress due to their medical condition.
These research projects leverage the company’s wholly-owned
network of more than 20 Canabo Medical Clinics with over 50,000
patients. With the largest medical cannabis dataset in the world,
the company enables researchers to validate cannabis science,
product teams to innovate, and management to build a strong
portfolio of intellectual property. The division had already
generated $612,000 in revenue by the third quarter of 2018.
Appealing to Both Traders & Investors
Many cannabis stocks appeal to active traders that look for
important catalysts and price movements, but only a fraction of
these companies are also attractive on a fundamental basis to
long-term investors. Aleafia Health is an existing licensed
producer with an experienced management team, 98,000 kilograms per
year of production capacity expected this year, and a network of
medical cannabis clinics with over 50,000 patients.
The company already generates tangible revenue from its medical
cannabis clinics, research activities and supply
agreement with CannTrust Holdings Inc.. After merging with
Emblem Corp., the company has amassed a significant production
footprint that it’s expanding further through strategic
investments around the world. At the same time, its massive
cannabis dataset provides an invaluable competitive advantage.
Currently, the company trades with a market capitalization of
about $375 million, which is lower than many other licensed
producers. As the company scales up production and research
activity, investors may become increasingly interested in the
growing revenue and cash flow. The R&D activity could also pave
the way towards valuable revenue streams from licensing, which may
help boost revenue and margins over the long-term.
Click Here to Download Aleafia Health Inc.’s Investor
Presentation
Looking Ahead
Aleafia Health Inc. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA:
ARAH) represents a compelling opportunity within the nascent
cannabis industry. In addition to having a very active stock, the
company’s business has been rapidly expanding from both a
production and research standpoint. Investors may want to keep an
eye on the stock as it continues to focus on growing its operations
and announcing new research.
For more information, visit the company’s website
at www.aleafiahealth.com.
Click Here to Download Aleafia Health Inc.’s Investor
Presentation
Please follow the link to read the full article:
https://www.cannabisfn.com/aleafia-becomes-first-cannabis-stock-to-top-tsx-venture-50-performance-rankings/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media
network dedicated to the global cannabis industry, helps companies
operating in the space attract investors, capital, and publicity.
Since 2013, private and public cannabis companies in the US and
Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or
entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of
cannabis from the palm of your
hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the
Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment
advisor or broker-dealer. You should always consult with your own
independent legal, tax, and/or investment professionals before
making any investment decisions. The information provided
onhttp://www.cannabisfn.com (the ‘Site’) is either original
financial news or paid advertisements drafted by our in-house team
or provided by an affiliate. CannabisFN.com, a financial news media
and marketing firm enters into media buys or service agreements
with the companies that are the subject of the articles posted on
the Site or other editorials for advertising such companies.
We are not an independent news media provider. We make no
warranty or representation about the information including its
completeness, accuracy, truthfulness or reliability and we
disclaim, expressly and implicitly, all warranties of any kind,
including whether the Information is complete, accurate, truthful,
or reliable. As such, your use of the information is at your own
risk. Nor do we undertake any obligation to update the items
posted. CannabisFN.com received compensation for producing and
presenting high quality and sophisticated content on CannabisFN.com
along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC,
which owns CannabisFN.com and CFN Media, has been hired to create
awareness. Please follow the link below to view our full disclosure
outlining our
compensation: http://www.cannabisfn.com/legal-disclaimer/
Frank Lane
206-369-7050
Flane@cannabisfn.com
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/5b13f3ab-f155-41f1-918e-535b7e210cfc
The photo is also available at Newscom, www.newscom.com, and via
AP PhotoExpress.
Aleafia Health (TSXV:ALEF)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aleafia Health (TSXV:ALEF)
Historical Stock Chart
From Mar 2023 to Mar 2024